Internal Medicine, Pulmonary Disease · Bayamon, PR
NPI
1790878916
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Paseo San Pablo #100, Edificio Arturo Cadilla Suite 411
Bayamon, PR, 00961
Phone (787) 785-2085
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
414 services
Medicare patients, 2024
136
Average age 75
Drug cost, 2024
$1.5M
7,938 prescriptions
Company payments, 2025
$496
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raul A Rios Mollineda was code 99214 (office e&m - established), 251 times for 101 patients. In total Raul A Rios Mollineda billed 414 services in 13 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 251 | 101 | $93.42 | $23K |
| 94664 E&M - Miscellaneous | Office | 62 | 31 | $13.68 | $848 |
| 95811 Sleep Study | Office | 24 | 23 | $479.53 | $12K |
| 94375 Pulmonary Function Testing | Office | 15 | 15 | $30.57 | $459 |
| 94640 Treatment - Miscellaneous | Office | 15 | 15 | $6.28 | $94.2 |
| 99204 Office E&M - New | Office | 15 | 15 | $122.40 | $1,836 |
| 94727 Pulmonary Function Testing | Office | 11 | 11 | $35.05 | $386 |
| 94729 Pulmonary Function Testing | Office | 11 | 11 | $44.50 | $489 |
By year: 2022 $41K for 522 services; 2023 $39K for 437 services; 2024 $41K for 414 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raul A Rios Mollineda prescribed most often to Medicare patients was Montelukast Sodium, with 2,413 prescriptions and refills. In total Raul A Rios Mollineda wrote 7,938 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 2,413 | 3,156 | 690 | $24K |
| Fluticasone Propionate Generic | 616 | 727 | 241 | $11K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 594 | 942 | 210 | $26K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 591 | 676 | 185 | $147K |
| Levocetirizine Dihydrochloride Generic | 488 | 521 | 137 | $5,516 |
| Dexamethasone Generic | 394 | 396 | 255 | $10K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 371 | 379 | 90 | $251K |
| Symbicort Budesonide/Formoterol Fumarate | 237 | 257 | 89 | $57K |
| Breo Ellipta Fluticasone/Vilanterol | 207 | 220 | 49 | $90K |
| Methylprednisolone Generic | 157 | 157 | 112 | $1,755 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 137 | 143 | 35 | $20K |
| Azelastine Hcl Generic | 86 | 127 | 32 | $2,235 |
| Spiriva Respimat Tiotropium Bromide | 78 | 83 | 26 | $42K |
| Famotidine Generic | 67 | 85 | 26 | $581 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 66 | 66 | 11 | $32K |
Brand drugs: - claims; generic drugs: 5,469 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raul A Rios Mollineda $496 ($496 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $258.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.